Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin
…, S Ito, Y Ito, K Shimokata, H Kume - American journal of …, 2006 - atsjournals.org
Enhanced proliferation of smooth muscle cells contributes to airway remodeling of bronchial
asthma. Recently, statins, inhibitors of 3-hydroxy-3-methylglutaryl–coenzyme A reductase, …
asthma. Recently, statins, inhibitors of 3-hydroxy-3-methylglutaryl–coenzyme A reductase, …
RhoA/Rho-kinase as a therapeutic target in asthma
H Kume - Current medicinal chemistry, 2008 - ingentaconnect.com
Rho-kinase is an effector molecule of RhoA, a monomeric GTP-binding protein, and causes
Ca2+ sensitization via inactivation of myosin phosphatase. The major physiological …
Ca2+ sensitization via inactivation of myosin phosphatase. The major physiological …
Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins.
H Kume, MP Graziano… - Proceedings of the …, 1992 - National Acad Sciences
The regulation of membrane ion channels by guanine nucleotide-binding proteins (G proteins)
has been described in numerous tissues. This regulation has been shown to involve the …
has been described in numerous tissues. This regulation has been shown to involve the …
Mechanical stretch enhances IL-8 production in pulmonary microvascular endothelial cells
…, Y Numaguchi, M Ishii, M Kondo, H Kume… - Biochemical and …, 2009 - Elsevier
In patients with acute respiratory distress syndrome, mechanical over-distension of the lung
by a large tidal volume causes further damage and inflammation, called ventilator-induced …
by a large tidal volume causes further damage and inflammation, called ventilator-induced …
[HTML][HTML] Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia
…, T Iwanaga, Y Higashimoto, H Nakajima, H Kume… - Respiratory …, 2013 - Elsevier
Background and objective The effects of ambulatory oxygen for idiopathic pulmonary fibrosis
(IPF) patients without resting hypoxemia have not been elucidated. The purpose of this …
(IPF) patients without resting hypoxemia have not been elucidated. The purpose of this …
Actin Cytoskeleton Regulates Stretch-Activated Ca2+ Influx in Human Pulmonary Microvascular Endothelial Cells
S Ito, B Suki, H Kume, Y Numaguchi, M Ishii… - American journal of …, 2010 - atsjournals.org
During high tidal volume mechanical ventilation in patients with acute lung injury (ALI)/acute
respiratory distress syndrome (ARDS), regions of the lung are exposed to excessive stretch, …
respiratory distress syndrome (ARDS), regions of the lung are exposed to excessive stretch, …
Sphingosine 1-phosphate causes airway hyper-reactivity by rho-mediated myosin phosphatase inactivation
H Kume, N Takeda, T Oguma, S Ito, M Kondo… - … of Pharmacology and …, 2007 - ASPET
In the present study, we investigated whether extracellular sphingosine 1-phosphate (S1P)
is involved in airway hyper-reactivity in bronchial asthma. The effects of S1P on the response …
is involved in airway hyper-reactivity in bronchial asthma. The effects of S1P on the response …
Fat‐free mass index predicts survival in patients with idiopathic pulmonary fibrosis
…, H Sano, T Iwanaga, Y Higashimoto, H Kume… - …, 2017 - Wiley Online Library
Background and objective Detailed body composition, such as fat‐free mass, has not been
examined in idiopathic pulmonary fibrosis ( IPF ). We investigated whether the fat‐free mass …
examined in idiopathic pulmonary fibrosis ( IPF ). We investigated whether the fat‐free mass …
Physical activity in daily life in patients with idiopathic pulmonary fibrosis
…, H Sano, T Iwanaga, Y Higashimoto, H Kume… - Respiratory …, 2018 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is characterized by progressive impairment
of lung function and degradation of daily activity; however, this degradation has not been …
of lung function and degradation of daily activity; however, this degradation has not been …
[HTML][HTML] Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic
…, E Sando, H Sakuma, T Kobayashi, H Kume… - Clinical and …, 2023 - Springer
It is unclear whether molnupiravir has a beneficial effect on vaccinated patients infected with
the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We …
the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We …